glucagon has been researched along with Paraneoplastic Syndromes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clifton-Bligh, RJ; Gild, ML; Gill, AJ; Samra, J; Tacon, L; Tsang, V | 1 |
| Gómez Gómez, LA; Losada López, I; Masmiquel Comas, L; Nicolau Ramis, JA; Rodríguez Rodríguez, I | 1 |
| De Delas, JS; Echenique-Elizondo, M; Elorza, JL | 1 |
| Liu, JG; Liu, YJ; Wang, XL; Zhao, HJ | 1 |
| Marko, PB; Miljković, J; Zemljic, TG | 1 |
| Chaw, L; Hood, AF; Krop, TM | 1 |
| Wilkinson, DS | 1 |
| Benowitz, N; Fairley, HB; Ham, J; Kirby, BD; Schambelan, M | 1 |
| Böcker, W; Brink, M; Fischer-Colbrie, R; Freytag, G; Heitz, PU; Kirchmair, R; Klöppel, G; Schmid, KW | 1 |
| Strohm, WD | 1 |
| Cohen, PR; Mullans, EA | 1 |
| Dandrifosse, AC; Dandrifosse, G; Dandrifosse, JF; Piérard, G; Scheen, AJ | 1 |
| Khandekar, JD; Miller, HJ; Oyer, D; Vick, NA | 1 |
| Green, MD; Holmes, A; Kilpatrick, C; Proietto, J | 1 |
1 review(s) available for glucagon and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Topics: Adult; Diagnosis, Differential; Erythema; Female; Gastrointestinal Agents; Glucagon; Glucagonoma; Hemangiopericytoma; Humans; Hypoglycemia; Iatrogenic Disease; Insulin-Like Growth Factor II; Kidney Neoplasms; Liver Neoplasms; Necrosis; Pancreatic Neoplasms; Paraneoplastic Syndromes; Skin Diseases, Vesiculobullous | 1998 |
13 other study(ies) available for glucagon and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.
Topics: Carcinoma, Neuroendocrine; Glucagon; Glucagon-Secreting Cells; Humans; Hypercalcemia; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Mutation, Missense; Pancreatic Neoplasms; Paraneoplastic Syndromes; Receptors, Glucagon; Syndrome | 2018 |
[Glucagon perfusion in paraneoplastic hypoglycemia].
Topics: Antineoplastic Agents; Coma; Fatal Outcome; Female; Glucagon; Humans; Hypoglycemia; Infusions, Intravenous; Insulin-Like Growth Factor II; Mesothelioma; Middle Aged; Models, Biological; Palliative Care; Paraneoplastic Syndromes; Perfusion; Peritoneal Neoplasms; Protein Precursors; Recurrence | 2009 |
Migratory necrolytic erythema and glucagonoma.
Topics: Aged; Dermatitis; Erythema; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms; Paraneoplastic Syndromes | 2003 |
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Calcium; Carcinogens; Diethylnitrosamine; Edible Grain; Glucagon; Hormones; Insulin; Liver Function Tests; Liver Neoplasms, Experimental; Male; Organ Size; Paraneoplastic Syndromes; Rats; Rats, Sprague-Dawley; Selenium; Thyroid Hormones | 2006 |
Necrolytic migratory erythema associated with hyperglucagonemia and neuroendocrine hepatic tumors.
Topics: Antineoplastic Agents, Hormonal; Dermatitis; Erythema; Glucagon; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Paraneoplastic Syndromes | 2005 |
What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Topics: Erythema; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Pancreatic Neoplasms; Paraneoplastic Syndromes; Skin; Skin Diseases | 2008 |
[Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Topics: Adenoma, Islet Cell; Erythema; Female; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Middle Aged; Necrosis; Pancreatic Neoplasms; Paraneoplastic Syndromes | 1984 |
Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, Intravenous; Diagnosis, Differential; Glucagon; Hormones; Humans; Male; Paraneoplastic Syndromes; Phentolamine; Pheochromocytoma | 1983 |
Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells.
Topics: Antibodies, Monoclonal; Chromogranin A; Chromogranins; Glucagon; Glucagonoma; Humans; Immunoenzyme Techniques; Islets of Langerhans; Neuroendocrine Tumors; Neuropeptides; Pancreatic Neoplasms; Paraneoplastic Syndromes; Secretogranin II | 1994 |
[Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].
Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Diagnostic Imaging; Glucagon; Glucagonoma; Humans; Interferon-alpha; Liver Neoplasms; Male; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Paraneoplastic Syndromes; Quadriplegia | 1996 |
[Necrolytic migratory erythema].
Topics: Adrenal Cortex Hormones; Amino Acids; Diagnosis, Differential; Erythema; Fatty Acids, Essential; Glucagon; Glucagonoma; Humans; Necrosis; Pancreatic Neoplasms; Paraneoplastic Syndromes; Zinc | 1998 |
Neurologic involvement in glucagonoma syndrome: response to combination chemotherapy with 5-fluorouracil and streptozotocin.
Topics: Adenoma, Islet Cell; Adult; Central Nervous System Diseases; Drug Therapy, Combination; Fluorouracil; Glucagon; Humans; Male; Pancreatic Neoplasms; Paraneoplastic Syndromes; Streptozocin | 1979 |
Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma.
Topics: Aged; Evoked Potentials, Visual; Female; Glucagon; Glucagonoma; Humans; Octreotide; Optic Atrophy; Pancreatic Neoplasms; Paraneoplastic Syndromes; Visual Acuity | 1991 |